Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:00:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T11:51:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.0 to v3.7.1, while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T13:56:00.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, making the study record inaccessible. The content that previously displayed the study details and locations appears to be replaced by the error notice.
    Difference
    21%
    Check dated 2026-09-21T22:08:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study timeline on the page has been updated with new milestone dates: the last update is now 2026-09-09 and the primary completion is 2030-05-30. Related QC update dates (2026-09-07 and 2026-09) have also been added, refining the documented milestones.
    Difference
    0.2%
    Check dated 2026-09-14T18:22:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The displayed revision number was updated from v3.6.5 to v3.6.6, reflecting a software update to the page. This change does not alter the study information or content visible to users.
    Difference
    0.0%
    Check dated 2026-08-31T16:56:50.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.